Safety and efficacy of mosunetuzumab, a bispecific antibody, in patients with relapsed or refractory follicular lymphoma: a single-arm, multicentre, phase 2 study
Lihua E. Budde(City Of Hope National Medical Center), Laurie H. Sehn(Spinal Cord Injury BC), Matthew J. Matasar(Memorial Sloan Kettering Cancer Center), Stephen J. Schuster(University of Pennsylvania), Sarit Assouline(Jewish General Hospital), Pratyush Giri(Royal Adelaide Hospital), John Kuruvilla(Princess Margaret Cancer Centre), Miguel Canales(Hospital Universitario La Paz), Sascha Dietrich(Heidelberg University), Keith Fay(The University of Melbourne), Matthew Ku(St Vincent's Hospital Melbourne), Loretta J. Nastoupil(The University of Texas MD Anderson Cancer Center), Chan Y. Cheah(The University of Western Australia), Michael C. Wei, Shen Yin, Chi‐Chung Li, Huang Huang(Roche (Canada)), Antonia Kwan, Elicia Penuel, Nancy L. Bartlett(Washington University in St. Louis)
Cited by 419Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis